Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial
Download the PDF here.
This post appeared first on investingnews.com
What's your reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0